Neurocrine Biosciences Inc (NASDAQ:NBIX)

100.95
BATS BZX Real-Time Price
As of 1:39pm ET
 +0.12 / +0.12%
Today’s Change
64.72
Today|||52-Week Range
125.59
+41.37%
Year-to-Date

Today’s Trading

Previous close100.83
Today’s open101.05
Day’s range100.23 - 101.93
Volume276,139
Average volume (3 months)661,700
Market cap$9.2B
Data as of 1:39pm ET, 09/23/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+313.16%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+179.19%
P/E ratio530.5
Price/Sales15.10
Price/Book19.04

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp+1.16+0.58%
MRNAModerna Inc-0.23-1.27%
BLUEbluebird bio Inc-1.03-0.96%
BMRNBiomarin Pharmaceuti...-1.05-1.40%
Data as of 1:40pm ET, 09/23/2019

Financials

Next reporting dateOctober 30, 2019
EPS forecast (this quarter)$0.65
Annual revenue (last year)$451.2M
Annual profit (last year)$21.1M
Net profit margin4.68%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
Chief Financial Officer
Matthew C. Abernethy
Corporate headquarters
San Diego, California

Forecasts